Navigation Links
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Date:5/25/2010

SAN DIEGO, May 25 /PRNewswire/ -- aTyr announced today that John Mendlein, Ph. D., has joined their Board of Directors as Executive Chairman. The translation of aTyr's newly found class of proteins, resectins, into medicines of the future will benefit from Dr. Mendlein's experience in biologics, partnerships, and product strategy. Resectins may serve as potential replacement protein therapeutics or as targets for antagonists relevant to inflammation, blood disorders, and metabolic disease. These naturally occurring human proteins possess novel biological activities distinct from currently known pharmaceutical targets and products.

"aTyr has recently uncovered novel proteins and pathways important to human physiology and disease. Dr. Mendlein's experience in translating game changing scientific discoveries into novel therapeutics will help us reach our goal – to build a successful, entrepreneurial enterprise from resectin based medicines offering breakthroughs in patient care" says Jeff Watkins, CEO of aTyr Pharma. Expanding on Dr. Mendlein's role, Watkins adds:  "John has an accomplished track record in biologics and building biotechs from a strong, novel scientific foundation. On multiple occasions he parlayed a company's science into meaningful partnerships and product opportunities while navigating the realities of running a biotech business."

Professor Paul Schimmel of The Scripps Research Institute and co-founder of aTyr Pharma adds, "Dr. Mendlein is the kind of visionary leader who recognizes how new biologies can open doors to whole new classes of therapeutics and targets. His passion for delivering new medicines to patients and his experience in making this happen helps actualize the po
'/>"/>

SOURCE aTyr Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
2. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. Hank Plain Joins Morgenthaler Ventures as Partner
5. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
6. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
7. Dan Broderick Joins Prolog Ventures as Partner
8. Ingenuity Systems Joins Biomarkers Consortium
9. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
10. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
11. Progeniq Joins Microsoft in Bio IT Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... 03, 2015 , ... Sterlitech Corporation introduces the compact, quiet, ... analytical laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, an oil-free ... maintenance-free solution for a broad range of vacuum filtration applications. , Featuring a ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... the detection and quantification of partially hydrolyzed gluten in foods, has been accepted ... adopted the method “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Francois Vieillard as Sales & Marketing Director. , With more than 25 ... be responsible for reinforcing Tronics’ business development activities worldwide. He brings to the ...
(Date:7/30/2015)... CITY, Kan. , July 30, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the ... for companion animals, today announced that its strategic ... from a dose confirmation study of AT-016, an ... Aratana for the treatment of osteoarthritis pain in ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
... Life Technologies Corporation today announced that its Ion Personal ... Innovative New Product "MIP" Awards luncheon hosted by CONNECT in ... disruptive technology in the gene sequencing field. Since ... uptake in research labs around the world and has been ...
...  Puma Biotechnology, Inc., a development stage biopharmaceutical company, ... trials of Puma,s investigational drug PB272 (neratinib) were ... Cancer Symposium that is currently taking place in ... below: Safety and Efficacy ...
... MIAMI BEACH, Fla., Dec. 9, 2011  As hundreds ... at the International Society for Fertility Preservation,s 2nd ... in reproductive endocrinology, urology and oncology announced the ... coalition to help newly diagnosed cancer patients in ...
Cached Biology Technology:Life Technologies' Ion Personal Genome Machine Receives San Diego's CONNECT Most Innovative New Product Award 2Life Technologies' Ion Personal Genome Machine Receives San Diego's CONNECT Most Innovative New Product Award 3Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium 2Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium 3Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium 4Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium 5Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium 6Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservation's 2nd World Congress 2Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservation's 2nd World Congress 3
(Date:7/27/2015)... , July 27, 2015   Zynx ... and experience-based clinical improvement solutions, today announced that ... is now available on Android smartphones and tablets. ... and post-care organizations can use ZynxCarebook to securely ... patient,s condition, streamline care transitions to other care ...
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
(Date:7/9/2015)... 07, 2015 Research ... of the "Biometrics for Banking; Market & ... report to their offering. The adoption ... this growth and the forecast is that by ... for companies involved in delivering biometric systems to ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... burden of malaria remains the subject of "best guesses," ... remains "driven by perceptions and politics, rather than an ... in PLoS Medicine. , Simon Hay and Robert Snow ... that it has been almost 40 years since the ...
... in Fantastic Voyage, doctors might soon be able to ... find where and how much of a cancer treatment ... in a study published today in the open access ... and quantify molecules within individual mammalian or bacterial cells. ...
... a single gene, researchers can prevent skin stem cells from ... epidermal, sebaceous and hair cells. They say this finding could ... in the lab, for both research and potential therapies. , ... the ability to differentiate into multiple types of tissues, one ...
Cached Biology News:Fantastic Voyage: A new nanoscale view of the biological world 2Researchers identify a key regulator for skin stem cells 2
Request Info...
Immunogen: Heat inactivated bacterial cells of Salmonella enteriditis,paratyphi and typhimurium Storage: 4 C...
US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
... Clone/PAD: 3B8A10. ... to the C-terminal region ... Specificity: Specific for the ... Reactivity: Human (positive control: ...
Biology Products: